Insurance Companies Make It Difficult for Kids with Asthma to Get Biologics
November 16, 2026 | 2 min read
Biologics have been a godsend for many patients with severe asthma, including children. But new research from Kansas City investigators suggests insurance companies are throwing up barriers to the acquisition of these drugs for a lot of kids who need them.
The study, which was presented at the recent American Academy of Allergy, Asthma and Immunology meeting, reviewed 326 prescriptions for biologic medications written for pediatric patients by allergists between 2018 and 2026. The average age of the kids in the study was 11, and about half were male.
The most frequent biologic prescribed was omalizumab, at 55.8%, followed by dupilumab at 26%.
The authors found nearly every one of the prescriptions required insurance approval before it could be filled, and about four in ten of the prescriptions were ultimately denied.
The reason for denial was most often either that the insurance company wanted the child to try another drug first, or the child did not meet the company’s rules for receiving the drug.
Even when kids did eventually get the drug, it generally took more than a month from the time the prescription was written. In some cases, families waited even longer for their children to receive the medications their physicians had prescribed for them.
“When a child’s asthma or allergies are out of control, every week counts,” said study co-author Aarti Pandya, MD, from Children’s Mercy Hospital. “Delays like these can put children at risk of serious health problems.”
Dr. Pandya and her colleagues believe their findings demonstrate the need for changes to the prior authorization process. “We hope this data helps start a conversation about making the approval process faster and simpler,” she said. “Children shouldn’t have to wait weeks for care their allergist knows they need immediately.”
The next step of your respiratory therapist journey begins now.
The AARC can help you discover your unique path and connect you with thousands of other dedicated RTs.